Serum D-asparagine concentration adjusted for eGFR could serve as a novel screening tool for urothelial carcinoma.

Autor: Yamamoto A; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Kawashima A; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. Electronic address: kawashima@uro.med.osaka-u.ac.jp., Sakai S; Department of Nephrology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Mita M; KAGAMI Inc., Ibaraki, Osaka, 567-0082, Japan., Sassi N; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Inoguchi S; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Horibe Y; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Yoshimura A; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Tani M; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Yutong L; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Okuda Y; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Oka T; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Uemura T; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Yamamichi G; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Ishizuya Y; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Hayashi T; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Yamamoto Y; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Kato T; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Hatano K; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Kakuta Y; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan., Imamura R; Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, 852-8501, Japan., Takahara S; Kansai Medical Clinic for Renal Transplantation, Toyonaka, Osaka, 560-0083, Japan., Kimura T; Department of Nephrology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan; Kansai Medical Clinic for Renal Transplantation, Toyonaka, Osaka, 560-0083, Japan., Nonomura N; Department of Urology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.

Publikováno v: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Nov 12; Vol. 733, pp. 150701. Date of Electronic Publication: 2024 Sep 14.

Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models.

Autor: Kawahara I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Yoshino H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Fukumoto W; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Arima J; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Saito S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Li G; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Fukuda I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Mitsuke A; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Sakaguchi T; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Inoguchi S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Matsushita R; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Nakagawa M; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Tatarano S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Yamada Y; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan., Enokida H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan.

Publikováno v: Molecular oncology [Mol Oncol] 2024 Sep; Vol. 18 (9), pp. 2196-2211. Date of Electronic Publication: 2024 Jun 14.

Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.

Autor: Sakaguchi T; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Mitsuke A; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Osako Y; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Yamada Y; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Takeyama H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Ogawa R; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Takahashi K; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Hirohata Y; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Yamamoto S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Arima J; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Fukumoto W; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Sugita S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Inoguchi S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Matsushita R; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Yoshino H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Tatarano S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan., Enokida H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, 890-8520, Kagoshima, Japan. henokida@m2.kufm.kagoshima-u.ac.jp.

Publikováno v: BMC nephrology [BMC Nephrol] 2024 Apr 08; Vol. 25 (1), pp. 124. Date of Electronic Publication: 2024 Apr 08.

Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinoma.

Autor: Fukumoto W; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Yoshino H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Horike SI; Division of Functional Genomics, Advanced Science Research Center, Kanazawa University, Kanazawa, Japan., Kawakami I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Tamai M; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Arima J; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Kawahara I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Mitsuke A; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Sakaguchi T; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Inoguchi S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Meguro-Horike M; Division of Functional Genomics, Advanced Science Research Center, Kanazawa University, Kanazawa, Japan., Tatarano S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Enokida H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Publikováno v: Cancer science [Cancer Sci] 2023 Oct; Vol. 114 (10), pp. 3946-3956. Date of Electronic Publication: 2023 Aug 06.

Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma.

Autor: Yoshino H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Electronic address: hyoshino@m3.kufm.agoshima-u.ac.jp., Tatarano S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Tamai M; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Tsuruda M; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Iizasa S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Arima J; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Kawakami I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Fukumoto W; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Kawahara I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Li G; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Sakaguchi T; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Inoguchi S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Yamada Y; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan., Enokida H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Publikováno v: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2022 Nov 19; Vol. 630, pp. 71-76. Date of Electronic Publication: 2022 Sep 16.